Streetbeat News

Earnings

IDXX

IDEXX Laboratories has increased its 2023 revenue guidance from $3.615B-$3.70B to $3.66B-$3.715B, which is in line with the consensus estimate of $3.67B.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 10:42 am

CRNT

Ceragon Networks reported Q2 earnings of $0.05 per share, beating the analyst consensus estimate of $0.01 by 400%. This is a 266.67% increase over losses from the same period last year. The company also reported quarterly sales of $86.15 million, beating the analyst consensus estimate of $78.44 million by 9.83%. This is a 21.90% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 10:41 am

MRK

Merck has revised its FY23 revenue guidance to $58.6B-$59.6B, up from the prior guidance of $57.7B-$58.9B and above the consensus of $53.18B. The company also forecasts an adjusted EPS of $2.95-$3.05, which is higher than the consensus of $2.60 but lower than the prior guidance of $6.88-$7.00.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 10:40 am

ZBH

Zimmer Biomet Holdings (NYSE:ZBH) reported Q2 earnings of $1.82 per share, in line with analyst consensus. The company's quarterly sales of $1.87 billion beat the analyst consensus estimate of $1.82 billion by 2.47 percent, marking a 4.94 percent increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 10:38 am

ESAB

ESAB (NYSE:ESAB) reported Q2 earnings of $1.21 per share, beating the analyst consensus estimate of $1.02 by 18.63%. This is a 12.04% increase from the same period last year. The company also reported quarterly sales of $720.42 million, beating the analyst consensus estimate of $656.86 million by 9.68%, a 8.96% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 10:38 am

GPK

Graphic Packaging Holding (NYSE:GPK) reported Q2 earnings of $0.66 per share, missing the analyst consensus estimate of $0.75 by 12%. The company also reported quarterly sales of $2.39 billion, missing the analyst consensus estimate of $2.47 billion by 3.28%. However, both earnings and sales increased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 10:37 am

IDXX

IDEXX Laboratories reported Q2 earnings of $2.67 per share, a 71.15% increase from the same period last year. The company also reported quarterly sales of $943.63 million, beating the analyst consensus estimate of $927.84 million by 1.70%.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 10:36 am

ETRN

Equitrans Midstream (ETRN) reported Q2 earnings of $0.12 per share, beating the analyst consensus estimate of $0.08 by 50%. However, the company's quarterly sales of $318.47 million missed the analyst consensus estimate of $325.07 million by 2.03%. This represents a 9.09% increase in earnings and a 3.09% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 10:36 am

LEA

Lear Corporation (NYSE:LEA) reported Q2 adjusted earnings of $3.33 per share, beating the analyst consensus estimate of $3.21 by 3.74%. This is an 86.03% increase from the same period last year. The company also reported quarterly sales of $6.00 billion, surpassing the analyst consensus estimate of $5.86 billion by 2.39%, marking an 18.30% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 10:35 am

ETN

Eaton Corporation has increased its FY23 adjusted EPS guidance to $8.65-$8.85, up from the previous estimate of $8.45. The company also expects Q3 adjusted EPS to be $2.27-$2.37, higher than the estimated $2.24.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 10:34 am